Literature DB >> 18614528

Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain.

Matthew J Bottomley1, Paola Lo Surdo, Paolo Di Giovine, Agostino Cirillo, Rita Scarpelli, Federica Ferrigno, Philip Jones, Petra Neddermann, Raffaele De Francesco, Christian Steinkühler, Paola Gallinari, Andrea Carfí.   

Abstract

Histone deacetylases (HDACs) regulate chromatin status and gene expression, and their inhibition is of significant therapeutic interest. To date, no biological substrate for class IIa HDACs has been identified, and only low activity on acetylated lysines has been demonstrated. Here, we describe inhibitor-bound and inhibitor-free structures of the histone deacetylase-4 catalytic domain (HDAC4cd) and of an HDAC4cd active site mutant with enhanced enzymatic activity toward acetylated lysines. The structures presented, coupled with activity data, provide the molecular basis for the intrinsically low enzymatic activity of class IIa HDACs toward acetylated lysines and reveal active site features that may guide the design of class-specific inhibitors. In addition, these structures reveal a conformationally flexible structural zinc-binding domain conserved in all class IIa enzymes. Importantly, either the mutation of residues coordinating the structural zinc ion or the binding of a class IIa selective inhibitor prevented the association of HDAC4 with the N-CoR.HDAC3 repressor complex. Together, these data suggest a key role of the structural zinc-binding domain in the regulation of class IIa HDAC functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614528      PMCID: PMC3258910          DOI: 10.1074/jbc.M803514200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Class II histone deacetylases: versatile regulators.

Authors:  Eric Verdin; Franck Dequiedt; Herbert G Kasler
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

2.  MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes.

Authors:  Ian W Davis; Laura Weston Murray; Jane S Richardson; David C Richardson
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

4.  An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme.

Authors:  Kristin Moreth; Daniel Riester; Christian Hildmann; René Hempel; Dennis Wegener; Andreas Schober; Andreas Schwienhorst
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

Review 5.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

6.  Bone morphogenetic protein-2 stimulates Runx2 acetylation.

Authors:  Eun-Joo Jeon; Kwang-Youl Lee; Nam-Sook Choi; Mi-Hye Lee; Hyun-Nam Kim; Yun-Hye Jin; Hyun-Mo Ryoo; Je-Yong Choi; Minoru Yoshida; Norikazu Nishino; Byung-Chul Oh; Kyeong-Sook Lee; Yong Hee Lee; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2006-04-13       Impact factor: 5.157

7.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

8.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.

Authors:  Alessandro Vannini; Cinzia Volpari; Gessica Filocamo; Elena Caroli Casavola; Mirko Brunetti; Debora Renzoni; Prasun Chakravarty; Chantal Paolini; Raffaele De Francesco; Paola Gallinari; Christian Steinkühler; Stefania Di Marco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

9.  2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.

Authors:  Philip Jones; Matthew J Bottomley; Andrea Carfí; Ottavia Cecchetti; Federica Ferrigno; Paola Lo Surdo; Jesus M Ontoria; Michael Rowley; Rita Scarpelli; Carsten Schultz-Fademrecht; Christian Steinkühler
Journal:  Bioorg Med Chem Lett       Date:  2008-02-14       Impact factor: 2.823

10.  Crystal structure of a conserved N-terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains.

Authors:  Liang Guo; Aidong Han; Darren L Bates; Jue Cao; Lin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

View more
  112 in total

Review 1.  Histone/protein deacetylases and T-cell immune responses.

Authors:  Tatiana Akimova; Ulf H Beier; Yujie Liu; Liqing Wang; Wayne W Hancock
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

Review 2.  Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors.

Authors:  Daiqing Liao
Journal:  Drug Discov Today Technol       Date:  2015-11-03

3.  Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors.

Authors:  Christopher A Luckhurst; Perla Breccia; Andrew J Stott; Omar Aziz; Helen L Birch; Roland W Bürli; Samantha J Hughes; Rebecca E Jarvis; Marieke Lamers; Philip M Leonard; Kim L Matthews; George McAllister; Scott Pollack; Elizabeth Saville-Stones; Grant Wishart; Dawn Yates; Celia Dominguez
Journal:  ACS Med Chem Lett       Date:  2015-12-10       Impact factor: 4.345

4.  Plants Release Precursors of Histone Deacetylase Inhibitors to Suppress Growth of Competitors.

Authors:  Sascha Venturelli; Regina G Belz; Andreas Kämper; Alexander Berger; Kyra von Horn; André Wegner; Alexander Böcker; Gérald Zabulon; Tobias Langenecker; Oliver Kohlbacher; Fredy Barneche; Detlef Weigel; Ulrich M Lauer; Michael Bitzer; Claude Becker
Journal:  Plant Cell       Date:  2015-11-03       Impact factor: 11.277

5.  Analyses of cobalt-ligand and potassium-ligand bond lengths in metalloproteins: trends and patterns.

Authors:  Natércia F Brás; António J M Ribeiro; Marina Oliveira; Nathália M Paixão; Juan A Tamames; Pedro A Fernandes; Maria J Ramos
Journal:  J Mol Model       Date:  2014-05-22       Impact factor: 1.810

6.  Eating disorder predisposition is associated with ESRRA and HDAC4 mutations.

Authors:  Huxing Cui; Jarrette Moore; Sunbola S Ashimi; Brittany L Mason; Jordan N Drawbridge; Shizhong Han; Benjamin Hing; Abigail Matthews; Carrie J McAdams; Benjamin W Darbro; Andrew A Pieper; David A Waller; Chao Xing; Michael Lutter
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 7.  Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.

Authors:  Jeremy D Osko; David W Christianson
Journal:  Bioorg Med Chem Lett       Date:  2020-02-11       Impact factor: 2.823

8.  Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Authors:  Tasha B Toro; Terry J Watt
Journal:  FASEB J       Date:  2020-08-30       Impact factor: 5.191

9.  Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents.

Authors:  Rong He; Yufeng Chen; Yihua Chen; Andrei V Ougolkov; Jin-San Zhang; Doris N Savoy; Daniel D Billadeau; Alan P Kozikowski
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

10.  Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.

Authors:  Mercedes Lobera; Kevin P Madauss; Denise T Pohlhaus; Quentin G Wright; Mark Trocha; Darby R Schmidt; Erkan Baloglu; Ryan P Trump; Martha S Head; Glenn A Hofmann; Monique Murray-Thompson; Benjamin Schwartz; Subhas Chakravorty; Zining Wu; Palwinder K Mander; Laurens Kruidenier; Robert A Reid; William Burkhart; Brandon J Turunen; James X Rong; Craig Wagner; Mary B Moyer; Carrow Wells; Xuan Hong; John T Moore; Jon D Williams; Dulce Soler; Shomir Ghosh; Michael A Nolan
Journal:  Nat Chem Biol       Date:  2013-03-24       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.